Gilman Steven C

Former Director at VCEL; Director at AKBA; Director at MOMENTA PHARMACEUTICALS INC, and 2 more

Sold, on record
$17.6M
Dollars the filings state
Form 4 sales
38
Latest Oct 16, 2024
Form 144 notices
5
Proposed sales
Companies
5
Filed as an executive or holder

Companies

Sales by reason

4
Routine
15
Plan not stated
0
No plan
19
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale VCELRoutine
    Sep 4, 2024 2024

    Sold 5,000 shares at $48.58 ($243k)

    Gilman Steven C, Director

    10b5-1 planSold 31.3% of holdings ($777k position)11,000 shares leftFirst sale on recordFollows a Form 144Filing

  2. 2 Form 144 notice VCELNotice
    Sep 18, 2024 +14 days

    Filed to sell 5,834 shares ($266k)

    Gilman Steven C, Director

    10b5-1 planFiling

  3. 3 Form 4 sale VCELRoutine
    Sep 18, 2024 same day

    Sold 5,834 shares at $45.54 ($266k)

    Gilman Steven C, Director

    10b5-1 planSold 34.7% of holdings ($767k position)11,000 shares leftFollows a Form 144Filing

  4. 4 Form 144 notice VCELNotice
    Oct 2, 2024 +14 days

    Filed to sell 5,833 shares ($235k)

    Gilman Steven C, Director

    10b5-1 planFiling

  5. 5 Form 4 sale VCELRoutine
    Oct 2, 2024 same day

    Sold 5,833 shares at $40.35 ($235k)

    Gilman Steven C, Director

    10b5-1 planSold 34.7% of holdings ($679k position)11,000 shares leftFollows a Form 144Filing

  6. 6 Form 144 notice VCELNotice
    Oct 16, 2024 +14 days

    Filed to sell 5,833 shares ($241k)

    Gilman Steven C, Director

    10b5-1 plan1x usual sizeFiling

  7. 7 Form 4 sale VCELRoutine
    Oct 16, 2024 same day

    Sold 5,833 shares at $41.36 ($241k)

    Gilman Steven C, Director

    10b5-1 planSold 34.7% of holdings ($696k position)11,000 shares left1x usual sizeFollows a Form 144Filing

  8. 8 Form 144 notice VCELNotice
    May 30, 2025 +226 days

    Filed to sell 13,125 shares ($551k)

    Gilman Steven C, Former Director

    No 10b5-1 plan2.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (43)

Form 144 notices and Form 4 sales by Gilman Steven C
Source
May 30, 2025May 30, 2025VCELFormer DirectorForm 144 notice13,125$551kNoticeSEC
Oct 16, 2024Oct 18, 2024VCELDirectorForm 4 sale5,833$241k34.7%RoutineSEC
Oct 16, 2024Oct 16, 2024VCELDirectorForm 144 notice5,833$241kNoticeSEC
Oct 2, 2024Oct 4, 2024VCELDirectorForm 4 sale5,833$235k34.7%RoutineSEC
Oct 2, 2024Oct 2, 2024VCELDirectorForm 144 notice5,833$235kNoticeSEC
Sep 18, 2024Sep 20, 2024VCELDirectorForm 4 sale5,834$266k34.7%RoutineSEC
Sep 18, 2024Sep 18, 2024VCELDirectorForm 144 notice5,834$266kNoticeSEC
Sep 4, 2024Sep 5, 2024VCELDirectorForm 4 sale5,000$243k31.3%RoutineSEC
Sep 4, 2024Sep 4, 2024VCELDirectorForm 144 notice5,000$245kNoticeSEC
Jun 3, 2022Jun 7, 2022AKBADirectorForm 4 sale4,567$2k9.5%Plan not statedSEC
Apr 29, 2022May 2, 2022VCELDirectorForm 4 sale900$28k14.8%Plan not statedSEC
Nov 29, 2021Dec 1, 2021VCELDirectorForm 4 sale5,000$196k58.8%UnusualSEC
Oct 27, 2021Oct 28, 2021VCELDirectorForm 4 sale5,000$253k58.8%UnusualSEC
Sep 30, 2021Oct 1, 2021VCELDirectorForm 4 sale5,000$244k58.8%UnusualSEC
Jun 7, 2021Jun 9, 2021AKBADirectorForm 4 sale4,567$15k8.7%Plan not statedSEC
Aug 5, 2020Aug 7, 2020MOMENTA PHARMACEUTICALS INCDirectorForm 4 sale13,000$426k62.5%UnusualSEC
Jul 29, 2020Jul 30, 2020MOMENTA PHARMACEUTICALS INCDirectorForm 4 sale10,000$297k56.2%UnusualSEC
Jul 22, 2020Jul 23, 2020MOMENTA PHARMACEUTICALS INCDirectorForm 4 sale10,000$332k56.2%UnusualSEC
Jun 8, 2020Jun 9, 2020AKBADirectorForm 4 sale4,567$55k10.5%Plan not statedSEC
May 1, 2019May 3, 2019VCELDirectorForm 4 sale7,500$126k100.0%UnusualSEC
Feb 28, 2019Mar 4, 2019VCELDirectorForm 4 sale7,500$135k100.0%UnusualSEC
Dec 3, 2018Dec 4, 2018VCELDirectorForm 4 sale8,500$151k100.0%UnusualSEC
Sep 4, 2018Sep 6, 2018VCELDirectorForm 4 sale9,000$108k100.0%UnusualSEC
Jun 22, 2018Jun 26, 2018MOMENTA PHARMACEUTICALS INCDirectorForm 4 sale2,294$49k40.0%UnusualSEC
Jun 11, 2018Jun 12, 2018KERYX BIOPHARMACEUTICALS INCDirectorForm 4 sale1,334$7k7.1%Plan not statedSEC
May 29, 2018May 31, 2018KERYX BIOPHARMACEUTICALS INCDirectorForm 4 sale1,333$7k6.7%Plan not statedSEC
Oct 1, 2014Oct 2, 2014CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale48,125$3.1M63.6%UnusualSEC
Jul 28, 2014Jul 29, 2014CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale40,625$2.5M59.5%UnusualSEC
May 15, 2014May 15, 2014CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale16,340$1.1M37.2%UnusualSEC
May 14, 2014May 14, 2014CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,680$116k6.0%Plan not statedSEC
Feb 18, 2014Feb 19, 2014CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale2,645$198k9.7%Plan not statedSEC
Jan 2, 2014Jan 2, 2014CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale25,000$1.7M51.5%UnusualSEC
Jun 3, 2013Jun 3, 2013CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale15,125$824k39.2%UnusualSEC
May 16, 2013May 17, 2013CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,201$59k4.9%Plan not statedSEC
May 15, 2013May 16, 2013CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,017$49k4.4%Plan not statedSEC
May 14, 2013May 15, 2013CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,135$56k5.2%Plan not statedSEC
Feb 19, 2013Feb 20, 2013CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,233$51k6.3%Plan not statedSEC
Jan 2, 2013Jan 3, 2013CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale15,000$645k48.6%UnusualSEC
May 17, 2012May 17, 2012CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale20,000$831k52.1%UnusualSEC
May 16, 2012May 16, 2012CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,597$67k8.0%Plan not statedSEC
May 14, 2012May 15, 2012CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale1,135$47k7.0%Plan not statedSEC
Oct 26, 2011Oct 28, 2011CUBIST PHARMACEUTICALS INCEVP & Chief Scientific OfficerForm 4 sale71,250$2.8M85.1%UnusualSEC
May 17, 2010May 18, 2010CUBIST PHARMACEUTICALS INCSVP, Chief Scientific OfficerForm 4 sale1,035$23k15.6%Plan not statedSEC